BGM Group Ltd. (BGM) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

BGM Group Ltd. (BGM) closed at USD 9.55 on 2026-10-14, a change of -96.6 % over the past year, with a market capitalization of USD 114.71M.

BGM Group Ltd. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

BGM Group Ltd. key figures

Previous close

USD 9.55 (2026-10-14)

1-year change

-96.6 %

Market cap

USD 114.71M

Enterprise value

USD 48.6M

P/E ratio (trailing)

-2.19

P/E ratio (forward)

n/a

EPS (trailing)

-3.93

EPS (forward)

n/a

PEG ratio

n/a

Price to book

0.14

Revenue growth

69.8 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

1.49

Employees

n/a

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About BGM Group Ltd.

BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufacturing of medications that use oxytetracycline as an active ingredient. The company also provides licorice products, such as Gan Di Xin, a antitussive and expectorant medicine made from raw licorice materials; Qilian Shan licorice extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, an ingredient for medical preparation companies to produce compound licorice oral solutions. In addition, it offers traditional Chinese medicine derivatives products comprising Ahan antibacterial paste that is used to treat refractory chronic skin diseases; heparin products, including heparin sodium preparation, an ingredient for pharmaceutical companies to produce medications used in treating cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and sausage casings, such as Zhu Xiaochang sausage casings for culinary purposes. Further, the company provides Fertilizer products comprising Xiongguan organic fertilizers to improve crop yield, increase soil's chemical properties, and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers for plant growth. Additionally, it focuses on the AI-driven commercialization of DuXiaoBao platform to provide comprehensive and professional AI solutions and intelligent robot services for insurance companies, insurance brokers, and consumers. BGM Group Ltd. is based in Chengdu, China.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for BGM Group Ltd. and compare it with other stocks.